ReviewJournal of obesity & metabolic syndrome2025
Multimodal and Multidimensional Artificial Intelligence Technology in Obesity.
Review in Journal of obesity & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Applying Artificial Intelligence to Childhood Obesity: T2DM and MASLD Risk Predictive Models.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial Intelligence-Based Risk Stratification in Obesity Care: From Diagnosis to Personalised Treatment Pathways.Diagnostics (Basel, Switzerland) · 2026Review
- A multimodal, risk-stratified framework for AI-driven early risk prediction and personalised prevention in obesity.Frontiers in artificial intelligence · 2026Article
- The "Futile Labour" Paradox: occupational physical activity fails to offset diabetes burden and is associated with microvascular stress signals in rural older adults.Frontiers in public health · 2026Article
- Applications of artificial intelligence in cardiovascular risk detection and prediction among adults with obesity: a scoping review.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the prevalence of obesity is increasing worldwide, related treatment remains a complex challenge that requires multidimensional approaches. Recent advancements in artificial intelligence (AI) have led to the development of multimodal methods capable of integrating diverse types of data. These AI approaches utilize both multimodal data integration and multidimensional feature representations, enabling personalized, data-driven strategies for obesity management. AI can support obesity management through applications such as risk prediction, clinical decision support systems, large language models, and digital therapeutics. Several studies have shown that these AI-based weight loss programs can achieve significant weight reduction and behavioral changes. These AI systems can induce behavioral modifications through continuous personalized feedback and improve accessibility for people in underserved areas. However, these AI technologies must address issues such as data privacy and security, transparency and accountability, and consider the potential widening health disparities between individuals who have access to AI technology and those who do not, as well as strategies for sustained user engagement. Conducting long-term clinical trials and evaluations of cost-effectiveness across diverse, large-scale populations would facilitate the effective application of AI in obesity management, ultimately contributing to improvements in public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.